Package 42292-039-20

Brand: levothyroxine sodium

Generic: levothyroxine sodium
NDC Package

Package Facts

Identity

Package NDC 42292-039-20
Digits Only 4229203920
Product NDC 42292-039
Product ID 42292-039_3a991bf1-d9aa-b137-e063-6294a90af2cf
Description

100 BLISTER PACK in 1 CARTON (42292-039-20) / 1 TABLET in 1 BLISTER PACK (42292-039-01)

Marketing

Marketing Status
Marketed Since 2017-01-19
Brand levothyroxine sodium
Generic levothyroxine sodium
Sample Package No

Linked Drug Pages (1)

Levothyroxine Sodium ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3a991bf1-d9aa-b137-e063-6294a90af2cf", "openfda": {"unii": ["9J765S329G"], "rxcui": ["966248", "966249", "966253", "966270"], "spl_set_id": ["cd69c192-cd3f-47e6-b0a6-c536ffed5c4b"], "manufacturer_name": ["Mylan Institutional Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (42292-039-20)  / 1 TABLET in 1 BLISTER PACK (42292-039-01)", "package_ndc": "42292-039-20", "marketing_start_date": "20170119"}], "brand_name": "Levothyroxine Sodium", "product_id": "42292-039_3a991bf1-d9aa-b137-e063-6294a90af2cf", "dosage_form": "TABLET", "pharm_class": ["Thyroxine [CS]", "l-Thyroxine [EPC]"], "product_ndc": "42292-039", "generic_name": "levothyroxine sodium", "labeler_name": "Mylan Institutional Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levothyroxine Sodium", "active_ingredients": [{"name": "LEVOTHYROXINE SODIUM", "strength": "112 ug/1"}], "application_number": "ANDA076187", "marketing_category": "ANDA", "marketing_start_date": "20170119", "listing_expiration_date": "20261231"}